2013-01-07 20:32:39 -
Raleigh, N.C., Jan. 7, 2013 - INC Research, LLC, a therapeutically focused
clinical research organization (CRO) with a Trusted Process(®) for delivering
reliable results, today reported the completion of its CEO succession plan
announced in August 2012.
Effective Jan. 1, 2013, Jamie Macdonald, formerly Chief Operating Officer for
the Company, officially assumed the role of INC Research's new Chief Executive
Officer. Mr. Macdonald replaced James T. Ogle, who remains with the Company as
Chairman of the Board. Alistair Macdonald, previously President, Clinical
Development Services, assumed the role of Chief Operating Officer.
"With the completion of these changes and the additional executive appointments
made in recent months, INC Research is strategically positioned for continued
growth," said James Ogle, Chairman of the Board. "We greatly appreciate Jamie
and Alistair's contributions to date and look
forward to their future leadership
as we continue to advance INC Research as a leading provider of clinical
development solutions globally."
"I am excited about 2013 and the opportunities it holds for INC Research and our
customers," noted Jamie Macdonald, Chief Executive Officer for the Company. "We
will continue to leverage our enhanced global scale, renowned therapeutic
capability and enhanced Trusted Process(®) to offer increasingly innovative
clinical development solutions that improve efficiency and ultimately lead our
customers to make better decisions faster. The future for our industry and our
Company has never been brighter and we look forward to continuing to partner
with our customers in the delivery of new medicines to market to improve world
health."
About INC Research
INC Research is a therapeutically focused clinical research organization with a
high-performance reputation for conducting global clinical developmentprograms
of the highest integrity. Pharmaceutical and biotechnology companies look to INC
Research for a complete range of customized Phase I through Phase IV programs in
all therapeutic areas and innovative pediatric and women's health trials. The
company's Trusted Process(®) methodology and therapeutic foresight lead
customers to more confident, better-informed drug and device development
decisions. INC Research is headquartered in Raleigh, NC. For more information,
please visit www.incresearch.com or follow us at @inc_research.
Contact: Lori Dorer, Media +1 (513) 345-1685
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
[HUG#1668763]
